<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Antimicrobial Resistance &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/antimicrobial-resistance/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 25 Jan 2026 11:14:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Antimicrobial Resistance &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Revolutionizing Corynebacterium diphtheriae Strain Classification</title>
		<link>https://bioengineer.org/revolutionizing-corynebacterium-diphtheriae-strain-classification/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 25 Jan 2026 11:13:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[Antimikrobiyal Direnç]]></category>
		<category><![CDATA[bakteri suşlarının genomik veriye dayalı sınıflandırılmasıdır. 2.]]></category>
		<category><![CDATA[Corynebacterium diphtheriae]]></category>
		<category><![CDATA[İçeriğe uygun 5 etiket: `Genomik Taksonomi]]></category>
		<category><![CDATA[LIN codes]]></category>
		<category><![CDATA[LIN Kodları]]></category>
		<category><![CDATA[Makalenin içeriğine ve anahtar kelimelerine göre en uygun 5 etiket: **Genomic taxonomy]]></category>
		<category><![CDATA[Public health** **Kısa açıklama:** 1. **Genomic taxonomy:** Makalenin temel konusu]]></category>
		<category><![CDATA[Yüksek Verimli Dizileme` **Açıklama:** 1. **Genomik Taksonomi:** Makalenin ana konusu bakteri suşlarının genomik veriye dayalı sınıflandırılması]]></category>
		<guid isPermaLink="false">https://bioengineer.org/revolutionizing-corynebacterium-diphtheriae-strain-classification/</guid>

					<description><![CDATA[In an age where microbial resistance poses substantial threat to global health, understanding the intricacies of pathogens has never been more critical. The emergence of new strains and the ability of existing bacteria to adapt to changing environments necessitates a comprehensive understanding of their genomic architecture. In this context, researchers are increasingly turning to cutting-edge [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320676</post-id>	</item>
		<item>
		<title>Premature Antibiotic Stopping in Elderly ER Patients</title>
		<link>https://bioengineer.org/premature-antibiotic-stopping-in-elderly-er-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 03:38:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[acil serviste erken antibiyotik kesimi]]></category>
		<category><![CDATA[Antibiotic discontinuation]]></category>
		<category><![CDATA[antibiotic stewardship]]></category>
		<category><![CDATA[antibiyotik direnci riskleri]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[clinical outcomes]]></category>
		<category><![CDATA[Elderly ER patients]]></category>
		<category><![CDATA[geriatrik enfeksiyon yönetimi` **Açıklama:** 1. **yaşlı hastalarda antibiyot]]></category>
		<category><![CDATA[hasta uyumsuzluğu]]></category>
		<category><![CDATA[İşte bu yazı için 5 uygun Türkçe etiket: `yaşlı hastalarda antibiyotik tedavisi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/premature-antibiotic-stopping-in-elderly-er-patients/</guid>

					<description><![CDATA[In the landscape of medical treatments, antibiotic therapies play a crucial role, particularly for vulnerable populations such as older adults. A recent retrospective study conducted by the research team led by Cezard et al., sheds light on a significant clinical issue: the premature discontinuation of antibiotic therapies initiated in emergency departments. This investigation, which focuses [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318697</post-id>	</item>
		<item>
		<title>Antimicrobial Resistance in Group A Strep During COVID</title>
		<link>https://bioengineer.org/antimicrobial-resistance-in-group-a-strep-during-covid/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 06:12:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[COVID-19 pandemic]]></category>
		<category><![CDATA[Group A Streptococcus]]></category>
		<category><![CDATA[pediatric infections]]></category>
		<category><![CDATA[Public Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/antimicrobial-resistance-in-group-a-strep-during-covid/</guid>

					<description><![CDATA[The COVID-19 pandemic has brought about unprecedented challenges across various sectors, but one of the critical issues that have emerged is the rise of antimicrobial resistance (AMR), particularly concerning pathogens like Group A Streptococcus (GAS). This is the focus of a new study conducted in Shenzhen, China, which has unveiled startling insights into the antimicrobial [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315157</post-id>	</item>
		<item>
		<title>Small Molecule Inhibits OmpV to Fight Cholera</title>
		<link>https://bioengineer.org/small-molecule-inhibits-ompv-to-fight-cholera/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 12 Dec 2025 04:35:15 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[Cholera treatment]]></category>
		<category><![CDATA[Makalenin içeriğine ve odak noktalarına göre en uygun 5 etiket: **OmpV inhibitor]]></category>
		<category><![CDATA[Small molecule therapy]]></category>
		<category><![CDATA[Vibrio cholerae** **Açıklama:** 1. **OmpV inhibitor:** Makalenin temel keşfi ve ana hedefi olan OmpV proteinini inhibe eden küçük molekül. 2]]></category>
		<guid isPermaLink="false">https://bioengineer.org/small-molecule-inhibits-ompv-to-fight-cholera/</guid>

					<description><![CDATA[In a groundbreaking development poised to transform the treatment of cholera pandemics, researchers have unveiled a novel small molecule inhibitor that targets a previously understudied bacterial protein known as OmpV in Vibrio cholerae. This innovative therapeutic strategy holds immense promise for combating one of the most persistent and deadly bacterial infections impacting global public health, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">306465</post-id>	</item>
		<item>
		<title>Reviewing the Pharmacological Impact of Quinazoline Derivatives</title>
		<link>https://bioengineer.org/reviewing-the-pharmacological-impact-of-quinazoline-derivatives/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 11 Dec 2025 17:38:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[anticancer agents]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[İşte bu içerik için 5 uygun etiket: **Quinazoline Derivatives]]></category>
		<category><![CDATA[Pharmacological Review]]></category>
		<guid isPermaLink="false">https://bioengineer.org/reviewing-the-pharmacological-impact-of-quinazoline-derivatives/</guid>

					<description><![CDATA[Quinazoline derivatives have emerged as a pivotal focus in pharmaceutical research due to their extensive range of biological activities. In a comprehensive review published in Molecular Diversity, researchers Manoharan and Perumal delve deep into the pharmacological effects of quinazoline-2,4(1H,3H)-dione derivatives. Their meticulous exploration underscores the potential these compounds have in treating various health conditions, making [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">306114</post-id>	</item>
		<item>
		<title>Ciprofloxacin Use in Kazakhstan: COVID-19’s Impact and AMR Strategies</title>
		<link>https://bioengineer.org/ciprofloxacin-use-in-kazakhstan-covid-19s-impact-and-amr-strategies/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 26 Nov 2025 15:02:29 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[antibiotic stewardship]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[Ciprofloxacin]]></category>
		<category><![CDATA[COVID-19 pandemic]]></category>
		<category><![CDATA[Kazakhstan Public Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ciprofloxacin-use-in-kazakhstan-covid-19s-impact-and-amr-strategies/</guid>

					<description><![CDATA[The overuse and inappropriate prescription of antibiotics have prompted global health experts to sound the alarm on the looming threat of antimicrobial resistance (AMR). This issue has reached critical levels across various countries, including Kazakhstan, where variations in antibiotic utilization can have profound effects on public health. A recent study authored by Kussainova, Kassym, Aljofan, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">301686</post-id>	</item>
		<item>
		<title>Novel Sulfone-Linked 1,2,4-Oxadiazole Derivatives: Design and Activity</title>
		<link>https://bioengineer.org/novel-sulfone-linked-124-oxadiazole-derivatives-design-and-activity/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 23 Oct 2025 04:36:37 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[1]]></category>
		<category><![CDATA[2]]></category>
		<category><![CDATA[4-oxadiazole derivatives]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[antivirulence factors]]></category>
		<category><![CDATA[biological activity]]></category>
		<category><![CDATA[sulfone moiety]]></category>
		<guid isPermaLink="false">https://bioengineer.org/novel-sulfone-linked-124-oxadiazole-derivatives-design-and-activity/</guid>

					<description><![CDATA[Recent advancements in medicinal chemistry have unveiled a fascinating class of compounds known as 1,2,4-oxadiazole derivatives. Researchers led by Zhu Z., Liu X., and Zou Y. have made significant strides in understanding the intricate design and synthesis of 1,2,4-oxadiazole derivatives that incorporate a sulfone moiety. The clinical relevance of these compounds is underscored by their [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">285636</post-id>	</item>
		<item>
		<title>Antimicrobial Resistance and Justice in Low-Income Countries</title>
		<link>https://bioengineer.org/antimicrobial-resistance-and-justice-in-low-income-countries/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 13 Oct 2025 14:07:57 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[health equity]]></category>
		<category><![CDATA[Intersectional Analysis]]></category>
		<category><![CDATA[Low-Income Countries]]></category>
		<category><![CDATA[Social Justice]]></category>
		<guid isPermaLink="false">https://bioengineer.org/antimicrobial-resistance-and-justice-in-low-income-countries/</guid>

					<description><![CDATA[Antimicrobial resistance (AMR) is not just a looming public health catastrophe; it is a complex social phenomenon deeply intertwined with issues of equity and justice, particularly in low- and middle-income countries (LMICs). A groundbreaking study published in Nature Communications by Davis, Limato, Monga, and colleagues presents an intersectional critical interpretive synthesis that sheds new light [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">280000</post-id>	</item>
		<item>
		<title>Tracing E. coli ST131 Spread in Households: One Health</title>
		<link>https://bioengineer.org/tracing-e-coli-st131-spread-in-households-one-health/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 26 Sep 2025 23:09:11 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[E. coli ST131]]></category>
		<category><![CDATA[Household transmission dynamics]]></category>
		<category><![CDATA[One Health framework]]></category>
		<category><![CDATA[Zoonotic reservoirs]]></category>
		<guid isPermaLink="false">https://bioengineer.org/tracing-e-coli-st131-spread-in-households-one-health/</guid>

					<description><![CDATA[In a groundbreaking study poised to reshape our understanding of microbial transmission within domestic environments, researchers have dissected the intricate dynamics of a notorious bacterial lineage: Escherichia coli sequence type 131 (ST131). This particular strain is a globally prevalent multidrug-resistant pathogen, often implicated in severe human infections such as urinary tract infections, bloodstream infections, and [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">272779</post-id>	</item>
		<item>
		<title>Breakthrough Rapid Tests for Sexually Transmitted Infections Set to Transform Diagnosis</title>
		<link>https://bioengineer.org/breakthrough-rapid-tests-for-sexually-transmitted-infections-set-to-transform-diagnosis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 05 Jun 2025 09:07:02 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[Diagnostic innovation]]></category>
		<category><![CDATA[EXPAR technology]]></category>
		<category><![CDATA[Point-of-care diagnostics]]></category>
		<category><![CDATA[Rapid STI testing]]></category>
		<guid isPermaLink="false">https://bioengineer.org/breakthrough-rapid-tests-for-sexually-transmitted-infections-set-to-transform-diagnosis/</guid>

					<description><![CDATA[In a groundbreaking advancement poised to revolutionize the diagnosis of sexually transmitted infections (STIs), Linear Diagnostics, a spin-out from the University of Birmingham, has secured £1 million in funding aimed at bringing to fruition a rapid, near-patient diagnostic platform. This novel device, developed in partnership with the National Institute for Health and Care Research (NIHR) [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">248445</post-id>	</item>
		<item>
		<title>Strengthening Global Health: SHEA Advocates for Ongoing U.S. Support of the World Health Organization</title>
		<link>https://bioengineer.org/strengthening-global-health-shea-advocates-for-ongoing-u-s-support-of-the-world-health-organization/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 21 Jan 2025 21:30:50 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antimicrobial Resistance]]></category>
		<category><![CDATA[Global Health Partnerships]]></category>
		<category><![CDATA[Pandemic Preparedness]]></category>
		<category><![CDATA[Public Health Security]]></category>
		<category><![CDATA[WHO Collaboration]]></category>
		<guid isPermaLink="false">https://bioengineer.org/strengthening-global-health-shea-advocates-for-ongoing-u-s-support-of-the-world-health-organization/</guid>

					<description><![CDATA[The Society for Healthcare Epidemiology of America (SHEA) has issued an urgent appeal stressing the critical importance of global collaborations in combating health threats that challenge societies both domestically and internationally. In the face of a pivotal moment for public health, SHEA urges a reconsideration of the decision to sever ties with the World Health [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">234422</post-id>	</item>
	</channel>
</rss>
